Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with Aggressive T-Cell Malignancies in a Phase I/II Trial

Authors :: Chitra Hosing
Eric McLaughlin
Zachary Braunstein
Benigno C Valdez
Lai Wei
Uday R Popat
Borje S Andersson
Sumithira Vasu
Karilyn T. Larkin
Samantha Jaglowski
Sam Penza
Ayman Saad
Hannah Choe
Sarah A Wall
Alex Cash
Robin Nakkula
Richard E Champlin
Marcos J.G. de Lima
Dean Anthony Lee
Jonathan E Brammer
Source :: Blood. 140:1885-1886
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools